News

The patents provide protection in a market where approximately 18,000 new cases of acute myelogenous leukemia (AML) are diagnosed each year and the trend in overall incidence of

Pipex’s anti-copper product candidate oral tetrathiomolybdate (TTM), a thiomolybdate covered by this notice of allowance, has demonstrated a 40% reduction in insoluble amyloid-beta (p < 0.05), a key

The patent includes pharmaceutical compositions, methods of treatment, and combination kits. The patent applies to the use of Xyfid as well as to a range of methods designed

AmpB is a generic drug that has been in use for approximately 50 years and is considered one of the most effective agents in the treatment of systemic

Based upon recent meetings in Shenzhen, China, it is anticipated that Jade Pharmaceutical (JPI) and Guangzhou Lazon Pharmacy (GLP) will work towards completing the acquisition of GLP by

This open label trial is evaluating the safety and efficacy of Curaxin CBLC102 for use in treating patients with hormone-refractory metastatic prostate cancer. The planned enrollment of 32

As part of the agreement, NextRx will continue to provide Blue Cross of Idaho with pharmacy benefits management services for their individual, group and Medicare Part D members.

The SunPill is a proprietary combination of ingredients with powerful antioxidant properties that help the body’s own natural defense when it comes to exposure to the sun. XenaCare

View 2 will enroll approximately 1,200 patients in up to 200 centers in Europe, Asia Pacific, Japan and Latin America. The first Phase III trial, View 1, began